In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19

B. R. Bharath; Hrishikesh Damle; Shiban Ganju; Latha Damle

doi:https://doi.org/10.12688/f1000research.24143.1

doi.org/10.12688/f1000research.24143.1

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19

,

,

..., Latha Damle

2

F1000Research

Volume: 9, Pages: 663 - 663

Published: Jul 1, 2020

Abstract

Background: Human coronavirus (SARS-CoV-2) is causing a pandemic with significant morbidity and mortality. As no effective novel drugs are available currently, drug repurposing is an alternative intervention strategy. Here we present an in silico drug repurposing study that implements successful concepts of computer-aided drug design (CADD) technology for repurposing known drugs to interfere...

Paper Fields

Paper Details

Title

In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19

DOI

doi.org/10.12688/f1000research.24143.1

Published Date

Jul 1, 2020

Journal

F1000Research

Volume

9

Pages

663 - 663

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History